Stocks and InvestingStocks and Investing
Tue, January 25, 2022
Mon, January 24, 2022
Sun, January 23, 2022
Sat, January 22, 2022
Fri, January 21, 2022
Thu, January 20, 2022

Carter Gould Maintained (BIIB) at Hold with Decreased Target to $244 on, Jan 20th, 2022


Published on 2024-10-27 19:21:46 - WOPRAI, Carter Gould
  Print publication without navigation


Carter Gould of Barclays, Maintained "Biogen Inc." (BIIB) at Hold with Decreased Target from $280 to $244 on, Jan 20th, 2022.

Carter has made no other calls on BIIB in the last 4 months.



There are 20 other peers that have a rating on BIIB. Out of the 20 peers that are also analyzing BIIB, 11 agree with Carter's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Yatin Suneja of "Guggenheim" Downgraded from Strong Buy to Hold and Decreased Target to $202 on, Thursday, January 13th, 2022
  • Salim Syed of "Mizuho" Maintained at Hold with Decreased Target to $207 on, Wednesday, January 12th, 2022
  • Laura Chico of "Wedbush" Maintained at Hold with Decreased Target to $195 on, Wednesday, January 12th, 2022
  • Christopher Raymond of "Piper Sandler" Downgraded from Buy to Hold and Decreased Target to $216 on, Wednesday, January 12th, 2022
  • Geoff Meacham of "B of A Securities" Maintained at Hold with Decreased Target to $275 on, Thursday, December 23rd, 2021
  • Cory Kasimov of "JP Morgan" Maintained at Hold with Decreased Target to $276 on, Tuesday, December 21st, 2021
  • Brian Skorney of "Baird" Maintained at Hold with Decreased Target to $258 on, Tuesday, December 21st, 2021
  • Mohit Bansal of "Wells Fargo" Initiated at Hold and Held Target at $250 on, Thursday, December 9th, 2021
  • Salveen Richter of "Goldman Sachs" Initiated at Hold and Held Target at $271 on, Monday, December 6th, 2021
  • Brian Abrahams of "RBC Capital" Maintained at Hold with Decreased Target to $277 on, Friday, November 19th, 2021
  • Alethia Young of "Cantor Fitzgerald" Maintained at Hold with Decreased Target to $327 on, Friday, October 15th, 2021


These are the ratings of the 9 analyists that currently disagree with Carter


  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $270 on, Tuesday, January 18th, 2022
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $360 on, Tuesday, January 18th, 2022
  • Ami Fadia of "Needham" Maintained at Strong Buy with Decreased Target to $292 on, Wednesday, January 12th, 2022
  • Jay Olson of "Oppenheimer" Maintained at Buy with Decreased Target to $350 on, Wednesday, December 22nd, 2021
  • Marc Goodman of "SVB Leerink" Maintained at Buy with Decreased Target to $325 on, Monday, December 20th, 2021
  • Evan Seigerman of "BMO Capital" Initiated at Buy and Held Target at $315 on, Friday, November 19th, 2021
  • Phil Nadeau of "Cowen & Co." Maintained at Buy with Decreased Target to $375 on, Thursday, October 21st, 2021
  • Paul Matteis of "Stifel" Maintained at Strong Buy with Decreased Target to $344 on, Friday, October 15th, 2021
  • Michael Yee of "Jefferies" Maintained at Strong Buy with Decreased Target to $400 on, Friday, October 8th, 2021